Results 211 to 220 of about 272,522 (346)
Direct in‐scope suction (DISS) ureteroscopy: techniques, outcomes and future directions
Objective To provide an overview of direct in‐scope suction (DISS) ureteroscopy, an emerging technology that integrates suction directly into the ureteroscope with the aim of enhancing stone clearance, improving visualisation, and reducing intrarenal pressure during ureteroscopic stone surgery.
Parth U. Patel +6 more
wiley +1 more source
Correction: Survey of Pediatric Cardiologists on Screening for Conditions Associated with Sudden Cardiac Death. [PDF]
Schlondrop JL +3 more
europepmc +1 more source
An Autopsy Study of Sudden Cardiac Deaths among Young Adults
Vinayaka K Prasanna +2 more
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Late gadolinium enhancement imaging and sudden cardiac death. [PDF]
Prasad SK +5 more
europepmc +1 more source
Over the past decade, there has been a significant decrease in the hospital mortality of patients with coronary artery disease. However, sudden cardiac death, which accounts for the majority of deaths from coronary artery disease, hasbeen little affected.
openaire +1 more source
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev +36 more
wiley +1 more source
Sudden cardiac death due to intussusception of a coronary artery: a case report. [PDF]
Attico F +4 more
europepmc +1 more source
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy +10 more
wiley +1 more source

